Cargando…
The transport of nifurtimox, an anti-trypanosomal drug, in an in vitro model of the human blood–brain barrier: Evidence for involvement of breast cancer resistance protein
Human African trypanosomiasis (HAT) is a parasitic disease affecting sub-Saharan Africa. The parasites are able to traverse the blood–brain barrier (BBB), which marks stage 2 (S2) of the disease. Delivery of anti-parasitic drugs across the BBB is key to treating S2 effectively and the difficulty in...
Autores principales: | Watson, Christopher P., Dogruel, Murat, Mihoreanu, Larisa, Begley, David J., Weksler, Babette B., Couraud, Pierre O., Romero, Ignacio A., Thomas, Sarah A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier/North-Holland Biomedical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281990/ https://www.ncbi.nlm.nih.gov/pubmed/22200378 http://dx.doi.org/10.1016/j.brainres.2011.11.053 |
Ejemplares similares
-
The hCMEC/D3 cell line as a model of the human blood brain barrier
por: Weksler, Babette, et al.
Publicado: (2013) -
A human-derived neurovascular unit in vitro model to study the effects of cellular cross-talk and soluble factors on barrier integrity
por: Barberio, Chiara, et al.
Publicado: (2022) -
Nifurtimox Activation by Trypanosomal Type I Nitroreductases Generates Cytotoxic Nitrile Metabolites
por: Hall, Belinda S., et al.
Publicado: (2011) -
Matrix metalloproteinase-9 activity and a downregulated Hedgehog pathway impair blood-brain barrier function in an in vitro model of CNS tuberculosis
por: Brilha, Sara, et al.
Publicado: (2017) -
Genome-wide RNAi screens in African trypanosomes identify the nifurtimox activator NTR and the eflornithine transporter AAT6
por: Baker, Nicola, et al.
Publicado: (2011)